■许多研究探索了斋月禁食对非酒精性脂肪性肝病(NAFLD)的影响。因此,本系统综述的目的是分析和总结有关斋月禁食对NAFLD患者影响的所有临床研究.
■我们对Embase进行了全面搜索,科克伦,和PubMed数据库从成立到2023年9月1日。所有关于斋月禁食对NAFLD患者影响的临床研究都包括在内。
■总共,6项研究纳入了3,97例NAFLD患者,包括5项前瞻性研究和1项回顾性研究.所有六项研究均被评估为高质量。斋月禁食可能为NAFLD患者提供潜在的好处,包括体重的改善,身体成分,心脏代谢危险因素,葡萄糖曲线,肝脏参数,和炎症标记。
■斋月禁食可能是NAFLD的有效饮食干预。然而,研究斋月禁食对NAFLD患者影响的研究数量相对有限.因此,我们需要更多高质量的研究来进一步了解斋月禁食对NAFLD的益处.
■https://inplasy.com,标识符202390102。
UNASSIGNED: Numerous studies have explored the impacts of Ramadan fasting on Non-alcoholic fatty liver disease (NAFLD). Therefore, the objective of this systematic
review was to analyze and summarize all clinical studies regarding the impacts of Ramadan fasting for patients with NAFLD.
UNASSIGNED: We performed a comprehensive search of the Embase, Cochrane, and PubMed databases from inception to September 1, 2023. All clinical studies concerning the impacts of Ramadan fasting on patients with NAFLD were included.
UNASSIGNED: In total, six studies with 397 NAFLD patients comprising five prospective studies and one retrospective study were included in the systematic
review. All six studies were assessed as high-quality. Ramadan fasting may offer potential benefits for patients with NAFLD, including improvements in body weight, body composition, cardiometabolic risk factors, glucose profiles, liver parameters, and inflammation markers.
UNASSIGNED: Ramadan fasting might be an effective dietary intervention for NAFLD. However, the number of studies examining the impacts of Ramadan fasting for patients with NAFLD is relatively limited. Therefore, more high-quality research is needed to further our understanding of the benefits of Ramadan fasting for NAFLD.
UNASSIGNED: https://inplasy.com, identifier 202390102.